Dr RR Baliga's "Got Knowledge Doc" Podkast

🧪❤️ Are preservatives in ultra-processed foods quietly increasing cardiovascular risk?

A major analysis from the NutriNet-Santé cohort published in the European Heart Journal followed >112,000 participants and linked several commonly used food additives with higher rates of hypertension and cardiovascular disease.

Notable signals emerged for sodium nitrite, potassium sorbate, sulphites, erythorbates, citric acid, and ascorbic acid additives.

This study reminds us that nutrition science is moving beyond calories and macronutrients toward the biological effects of industrial food processing itself. 🍔⚠️

Fresh foods may still be the best "cardiovascular preservative." 🫀

#Cardiology #Nutrition #PreventiveCardiology #HeartDisease #Hypertension #MedicalPodcast

🦠 The INTEGRAL-1 trial in The Lancet delivers exciting data for resistant urinary tract infections. Cefepime–nacubactam achieved both noninferiority AND superiority vs imipenem–cilastatin in complicated UTI and acute pyelonephritis.

⚡ Strong microbiological eradication, promising ESBL activity, and favorable safety profiles suggest an important future role in carbapenem-sparing strategies.

#UTI #Lancet #AntimicrobialResistance #ESBL #InfectiousDiseases #MedicalPodcasts

😴💊 Could a pill transform the treatment of obstructive sleep apnea?

The SynAIRgy Phase 3 trial of AD109 (aroxybutynin + atomoxetine) showed significant reductions in apnea–hypopnea index and hypoxic burden in patients unable to tolerate CPAP therapy. 🌙🫁

A once-nightly oral therapy targeting upper airway neuromuscular dysfunction may represent a new frontier in sleep medicine. Fascinating data with important implications for cardiovascular and metabolic health. 🫀📊

#SleepApnea #OSA #AD109 #SleepMedicine #RespiratoryMedicine #MedicalPodcasts #ClinicalTrials #PrecisionMedicine

⚕️ "If you want to understand the health of a population, look at the air they breathe, the water they drink, and the places where they live."

More than 2,400 years ago, Hippocrates transformed medicine by arguing that disease had natural—not supernatural—causes. His emphasis on clinical observation, ethics, prognosis, professionalism, and compassionate care laid the foundation for modern medicine.

The Hippocratic Oath remains one of the most enduring ethical pledges in human history. 📜✨

A timeless reminder that great medicine begins not only with science—but with humility, observation, and humanity

💊 Can weight loss achieved with injectable GLP-1 therapies be maintained using an oral agent?

The ATTAIN-MAINTAIN phase 3b trial published in Nature Medicine evaluated once-daily oral orforglipron after prior tirzepatide or semaglutide therapy. Patients maintained substantially more prior weight reduction versus placebo over 52 weeks, while preserving cardiometabolic benefits. 🌍⚖️

A fascinating glimpse into the future of scalable obesity care: oral incretin therapy may improve adherence, accessibility, and long-term maintenance.

#Obesity #GLP1 #Orforglipron #NatureMedicine #Cardiology #Endocrinology #MedicalPodcast #PhysicianEducation

👁️ New NEJM correspondence highlights a potentially important ophthalmic signal linked to dulaglutide therapy. Two patients developed choroidal lymphoid hyperplasia with painless visual loss within months of GLP-1 receptor agonist initiation. Remarkably, ocular and systemic findings rapidly resolved after stopping dulaglutide.

As GLP-1 therapies expand across diabetes, obesity, and cardiometabolic medicine, clinicians should remain vigilant for emerging ocular adverse events.

A fascinating intersection of endocrinology, immunology, and ophthalmology. 🔬💉👓

#NEJM #GLP1 #Dulaglutide #Ophthalmology #Diabetes #Retina #Cardiology #ObesityMedicine #PrecisionMedicine #MedicalEducation

🫀 Scar. Signal. Survival.

A major new JAMA study from the NHLBI Hypertrophic Cardiomyopathy Registry followed 2,698 patients for nearly 7 years and demonstrated that advanced cardiac magnetic resonance imaging and NT-proBNP markedly improve prediction of adverse outcomes in hypertrophic cardiomyopathy.

📌 Key findings: • Late gadolinium enhancement (fibrosis burden) strongly predicted events • LGE ≥9% of LV mass substantially increased risk • LV mass index, LV systolic dysfunction, and NT-proBNP independently predicted outcomes • Traditional markers alone may miss important risk signals

This work moves HCM risk assessment beyond simple wall thickness toward a multidimensional precision cardiology approach.

📖 JAMA. Published online May 11, 2026. #Cardiology #HCM #HypertrophicCardiomyopathy #CardiacMRI #CMR #HeartFailure #SuddenCardiacDeath #PrecisionMedicine #CardioTwitter #JAMA

🧠 Six landmark stroke investigations published in NEJM, JAMA, and Lancet are redefining modern reperfusion science.

🔹 ORIENTAL-MeVO: Thrombectomy improved outcomes in selected medium-vessel occlusion strokes. 🔹 TNK-PLUS: Bridging tenecteplase before EVT in the late window showed no added benefit. 🔹 CHOICE-2: Intra-arterial alteplase after successful thrombectomy improved excellent recovery but raised mortality concerns. 🔹 INSTANT: Early tirofiban after inadequate tenecteplase response improved 90-day outcomes. 🔹 TAPIS: Early ticagrelor + aspirin after thrombolysis improved functional recovery without excess major bleeding. 🔹 ATLAS: EVT benefited large-core stroke patients up to 24 hours after onset.

Together, these studies shift the conversation from simply reopening arteries toward optimizing tissue-level reperfusion, patient selection, and microvascular recovery. 🚑⚡

#Stroke #Neurology #Thrombectomy #JAMA #NEJM #Lancet #Neurointervention #Tenecteplase #Tirofiban #Cardiology

😴🧠 How much sleep is "just right" for healthy ageing?

A remarkable Nature study of ~500,000 UK Biobank participants demonstrated a striking U-shaped relationship between sleep duration and biological ageing across 23 ageing clocks, 17 organs, and 3 omics platforms. 🌙🧬

Both short (8 h) sleep were associated with accelerated ageing, higher systemic disease burden, and increased all-cause mortality. The biologic "sweet spot" appeared to be ~6–8 hours/night. ⏳❤️

An elegant reminder that sleep is not passive rest — it is active systemic repair.

Source: The MULTI Consortium et al. Nature (2026) DOI: 10.1038/s41586-026-1052

🫀 Old drug. New evidence. Renewed relevance.

Two major JAMA studies published in 2026 revisit the role of digoxin/digitalis glycosides in modern cardiovascular care.

📊 A meta-analysis of 9,013 patients with HFmrEF/HFrEF showed reduced worsening heart failure events without increased mortality.

🌍 The Dig-RHD randomized trial from India demonstrated that digoxin reduced death or worsening heart failure in symptomatic rheumatic heart disease with minimal toxicity.

Key message: 💊 Digoxin may still have an important role as affordable adjunctive therapy—especially in resource-limited settings and carefully selected patients.

Sometimes the oldest medicines still have new stories to tell.

#Cardiology #HeartFailure #Digoxin #RheumaticHeartDisease #JAMA #Digitalis #HFmrEF #HFrEF #GlobalHealth #CardioTwitte